Log In
BCIQ
Print this Print this
 

APC-100, CPC-100

  Manage Alerts
Collapse Summary General Information
Company Colby Pharmaceutical Co.
DescriptionAnti-androgenic and anti-inflammatory, signal transduction inhibitor
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationProstate cancer
Indication DetailsTreat castration-resistant prostate cancer (CRPC)
Regulatory Designation
PartnerAdamis Pharmaceuticals Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/08/2010

Undisclosed

0

0

Get a free BioCentury trial today